Many children with melanoma do not meet ABCDE criteria

July 19, 2013
Many children with melanoma do not meet ABCDE criteria
A considerable proportion of children with melanoma do not present with conventional melanoma detection criteria (asymmetry, border irregularity, color variegation, diameter > 6 mm, and evolution), according to a study published in the June issue of the Journal of the American Academy of Dermatology.

(HealthDay)—A considerable proportion of children with melanoma do not present with conventional melanoma detection criteria (asymmetry, border irregularity, color variegation, diameter >6 mm, and evolution [ABCDE]), according to a study published in the June issue of the Journal of the American Academy of Dermatology.

Kelly M. Cordoro, M.D., from the University of California in San Francisco, and colleagues conducted a involving 60 children with a diagnosis of melanoma and 10 children with ambiguous melanocytic tumors treated as melanoma, diagnosed before age 20 from 1984 to 2009. The patients were categorized by age: 0 to 10 years (19 patients, group A) and 11 to 19 years (51 patients, group B).

The researchers found that 60 and 40 percent of groups A and B, respectively, did not present with conventional ABCDE criteria. The most common features included amelanosis, bleeding, "bumps," uniform color, variable diameter, and de novo development. Significant between-group variation was observed in histopathological subtypes. Forty-four percent were considered histopathologically unclassifiable according to current melanoma subtypes. In groups A and B, 92 and 46 percent of patients, respectively, had stage IIA disease or higher (P = 0.05). One patient in group A and nine in group B died; 70 percent of these cases had amelanotic lesions and 60 percent had one or more major . Metastasis was predicted with Breslow thickness (adjusted odds ratio, 12.8).

"Additional ABCD detection criteria (Amelanotic; Bleeding, Bump; Color uniformity; De novo, any Diameter) used together with conventional ABCDE criteria may facilitate earlier recognition and treatment of in children," write the authors.

Explore further: Negative pigment network able to distinguish melanoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Negative pigment network able to distinguish melanoma

October 25, 2012
(HealthDay)—Negative pigment network (NPN) can be used to distinguish melanoma from Spitz nevus and other benign lesions, according to a study published online Oct. 11 in the Journal of the American Academy of Dermatology.

Risk of second primary melanoma up in pediatric patients

June 28, 2012
(HealthDay) -- Pediatric patients diagnosed with an invasive cutaneous melanoma have nearly double the relative risk of developing a subsequent primary melanoma, compared with adults, according to a study published online ...

Surgeons report melanoma recurs after 10 years in more than 6 percent of patients

June 27, 2013
Recurrence of melanoma skin cancer 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study, these patients tend to live ...

Pediatric melanomas are increasing two percent a year

April 16, 2013
(HealthDay)—The incidence of pediatric melanoma has increased by about 2 percent per year, and this incidence trend is influenced by gender, age, and stage at diagnosis, primary site, and ultraviolet (UV)-B exposure, according ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.